Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey (Preprint)

Author:

Huang XiaojieORCID,Yu MaoheORCID,Fu GengfengORCID,Lan GuanghuaORCID,Li LinghuaORCID,Yang JianzhouORCID,Qiao YingORCID,Zhao JinORCID,Qian Han-ZhuORCID,Zhang XiangjunORCID,Liu XinchaoORCID,Jin XiaORCID,Chen GuohongORCID,Jiang HuiORCID,Tang WeimingORCID,Wang ZixinORCID,Xu JunjieORCID

Abstract

BACKGROUND

HIV infection is a significant independent risk factor for both severe COVID-19 presentation at hospital admission and in-hospital mortality. Available information has suggested that people living with HIV and AIDS (PLWHA) could benefit from COVID-19 vaccination. However, there is a dearth of evidence on willingness to receive COVID-19 vaccination among PLWHA.

OBJECTIVE

The aim of this study was to investigate willingness to receive COVID-19 vaccination among a national sample of PLWHA in China.

METHODS

This cross-sectional online survey investigated factors associated with willingness to receive COVID-19 vaccination among PLWHA aged 18 to 65 years living in eight conveniently selected Chinese metropolitan cities between January and February 2021. Eight community-based organizations (CBOs) providing services to PLWHA facilitated the recruitment. Eligible PLWHA completed an online survey developed using a widely used encrypted web-based survey platform in China. We fitted a single logistic regression model to obtain adjusted odds ratios (aORs), which involved one of the independent variables of interest and all significant background variables. Path analysis was also used in the data analysis.

RESULTS

Out of 10,845 PLWHA approached by the CBOs, 2740 completed the survey, and 170 had received at least one dose of the COVID-19 vaccine. This analysis was performed among 2570 participants who had never received COVID-19 vaccination. Over half of the participants reported willingness to receive COVID-19 vaccination (1470/2570, 57.2%). Perceptions related to COVID-19 vaccination were significantly associated with willingness to receive COVID-19 vaccination, including positive attitudes (aOR 1.11, 95% CI 1.09-1.12; <i>P</i>&lt;.001), negative attitudes (aOR 0.96, 95% CI 0.94-0.97; <i>P</i>&lt;.001), perceived support from significant others (perceived subjective norm; aOR 1.53, 95% CI 1.46-1.61; <i>P</i>&lt;.001), and perceived behavioral control (aOR 1.13, 95% CI 1.11-1.14; <i>P</i>&lt;.001). At the interpersonal level, receiving advice supportive of COVID-19 vaccination from doctors (aOR 1.99, 95% CI 1.65-2.40; <i>P</i>&lt;.001), CBO staff (aOR 1.89, 95% CI 1.51-2.36; <i>P</i>&lt;.001), friends and/or family members (aOR 3.22, 95% CI 1.93-5.35; <i>P</i>&lt;.001), and PLWHA peers (aOR 2.38, 95% CI 1.85-3.08; <i>P</i>&lt;.001) was associated with higher willingness to receive COVID-19 vaccination. The overall opinion supporting COVID-19 vaccination for PLWHA on the internet or social media was also positively associated with willingness to receive COVID-19 vaccination (aOR 1.59, 95% CI 1.31-1.94; <i>P</i>&lt;.001). Path analysis indicated that interpersonal-level variables were indirectly associated with willingness to receive COVID-19 vaccination through perceptions (β=.43, 95% CI .37-.51; <i>P</i>&lt;.001).

CONCLUSIONS

As compared to PLWHA in other countries and the general population in most parts of the world, PLWHA in China reported a relatively low willingness to receive COVID-19 vaccination. The internet and social media as well as interpersonal communications may be major sources of influence on PLWHA’s perceptions and willingness to receive COVID-19 vaccination.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3